Delivery Order 36F79718D0524-36C24826N0684
Award Date 7/16/26
Potential Completion Date 7/16/31
Potential Value $249K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bay Pines, FL 33744, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 16 issued a purchase order to Veracyte, Inc. for genomic testing valued at $405,018, awarded June 1, 2024, with performance completion by May 31, 2029. The order is firm fixed price with no small business set-aside. Work is performed in Shreveport, Louisiana. The procurement incorporates diversity, equity, and inclusion objectives through Executive Order 14398. Veracyte delivers proprietary molecular diagnostic testing services, including thyroid nodule...
- The Veterans Integrated Service Network (VISN) 8, a civilian healthcare organization within the Department of Veterans Affairs, awarded a delivery order to Veracyte, Inc. for molecular thyroid testing services with a ceiling value of $413.7K. The award was made on September 1, 2024, with an ultimate completion date of August 31, 2029, under a firm fixed-price arrangement with no small business set-aside. This delivery order is issued under Veracyte's broader indefinite delivery vehicle...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a delivery order valued at $85,000 to Veracyte, Inc. for Afirma thyroid testing services supporting the Fargo VA Health Care System. This firm fixed-price delivery order, issued on May 1, 2026, is scheduled for completion by April 30, 2027. The award carries no small business set-aside designation and reflects the proprietary and specialized nature of Veracyte's genomic diagnostic capabilities. The work...
- Veterans Integrated Service Network 17 awarded a purchase order to Veracyte, Inc. for $451,200 on August 15, 2022. The order is a firm fixed-price purchase for genomic laboratory testing services, with place of performance in Dallas, Texas and an ultimate completion date of August 14, 2027. Veracyte delivers proprietary molecular diagnostic tests including Decipher Prostate Cancer and Afirma Genomic Sequencing Classifier testing for precision medicine applications across VA facilities within the...
- This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
- Veterans Integrated Service Network 5 issued a delivery order to Veracyte, Inc. on March 23, 2026, with a ceiling value of $412,750 for molecular testing services, under a firm fixed-price arrangement. Place of performance is Baltimore, MD. The order extends through March 22, 2031. Veracyte specializes in advanced genomic diagnostic testing for precision medicine applications, including proprietary molecular tests for prostate cancer risk assessment, thyroid nodule malignancy stratification, and...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a $12,928 delivery order to Veracyte, Inc. for thyroid testing services. This fixed-price contract with economic price adjustment authority has a completion date of September 30, 2026, and will be performed in Fayetteville, Arkansas. The award represents a non-set-aside delivery order issued without preferential contracting designations, reflecting the specialized and proprietary nature of Veracyte's...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a $697.2K firm fixed-price purchase order to Veracyte, Inc. on February 1, 2023, for reference laboratory services featuring thyroid molecular genomic sequencing diagnostics. The contract requires Veracyte to provide testing equivalent to the Afirma Genomic Sequencing Classifier (CPT 81546) and Afirma Xpression Atlas (CPT 0204U) to support physicians at Ralph H. Johnson VA Medical Center in Charleston, South...
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a delivery order valued at $1.62M by Veterans Integrated Service Network 8 on December 1, 2025, for genomic sequencing classifier services under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract, which carries a firm fixed price and no set-aside designation, extends through November 30, 2030, with performance taking place at Bay Pines, Florida. This delivery...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Veracyte, Inc. on January 1, 2026, for thyroid molecular genomic testing services with a ceiling value of $1.85M and an ultimate completion date of July 31, 2028. This non-set-aside contract is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and will be performed in Temple, Texas. Veracyte, a South San Francisco-based medical diagnostic...